Schedule of Non-cash Investing and Financing Activities and Supplemental Cash Flow Disclosures (Details) - USD ($) $ in Thousands |
6 Months Ended | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2025 |
Jun. 30, 2024 |
|||||||||||||
Non–cash investing and financing activities: | ||||||||||||||
Capital expenditures included in accrued liabilities | $ (15,692) | $ (1,120) | ||||||||||||
Equipment purchased in exchange for note payable | (560) | |||||||||||||
Common Stock issued to Bayswater as part of Bayswater Acquisition purchase price | [1] | 16,000 | ||||||||||||
Bayswater transaction costs included in accrued liabilities | 6,035 | |||||||||||||
Common Stock issuance costs included in accrued liabilities | [2] | 292 | ||||||||||||
Series F Preferred Stock issuance costs included in accrued liabilities | [3] | 1,113 | ||||||||||||
Common Stock issued upon conversion of Series D Preferred Stock | 8,475 | 4,120 | ||||||||||||
Common Stock issued upon conversion of Series F Preferred Stock | 4,772 | |||||||||||||
Common Stock issued upon conversion of Senior Convertible Note | [4] | 18,164 | ||||||||||||
Common Stock issued for Series F Preferred dividends | [5] | 3,289 | ||||||||||||
Series F Preferred Stock undeclared dividends | 1,647 | |||||||||||||
Remeasurement of Series F preferred stock | [6] | 73,101 | ||||||||||||
Series F Preferred Stock embedded derivatives | 1,130 | |||||||||||||
Series F Preferred Stock warrant liabilities | 43,718 | |||||||||||||
Additions to asset retirement obligation | 46 | |||||||||||||
Supplemental disclosure: | ||||||||||||||
Cash paid for interest | 6,971 | |||||||||||||
Cash paid for income taxes | ||||||||||||||
|